Jun Liu

This inventor holds 46 USPTO granted patents and 8 published patent applications and 12 EPO patents, primarily in Protein Formulations. Top assignees: Neology, Inc., Genentech, Inc., Novartis Ag. Active years: 2005-2023.

USPTO Granted Patents = 46 (Patent Applications = 8)

% Patents Active = 60.9

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 2.8

ph-index = 15

Forward Citations = 813(Granted Patents)

Location History:

Sherman Oaks, CA (US) (2006 - 2012)
South San Francisco, CA (US) (2016 - 2018)
San Diego, CA (US) (2008 - 2022)
Pacifica, CA (US) (2005 - 2023)
Redwood City, CA (US) (2022 - 2023)

Company Filing History:

Coherus Biosciences, Inc.

patents

5. 3 out of 10

Smartrac Technology Fletcher, Inc.

patents

6. 3 out of 17

Technocom Corporation

where one patent can have more than one assignee

Years Active: 2005-2023

Loading Chart...

Areas of Expertise:

Aqueous Formulations

Immunoconjugates

Protein Purification

Antibody Formulations

Anti-Counterfeiting

RFID Authentication

Privacy Preservation

Concentrated Formulations

Cancer Treatment

Heteroaryl Compounds

Document Authentication

Inventory Management

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11667702 - Stable aqueous formulations of aflibercept (2023-06-06),

2. 11648317 - Stable anti-CD79B immunoconjugate formulations (2023-05-16),

3. 11583584 - Stable protein compositions and methods of their use (2023-02-21),

4. 11576971 - Method of filling a container with no headspace (2023-02-14),

5. 11458138 - 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors (2022-10-04),

6. 11426446 - Stable aqueous formulations of aflibercept (2022-08-30),

7. 11071782 - Method of filling a container with no headspace (2021-07-27),

8. 10906934 - Protein purification methods (2021-02-02),

9. 10422007 - Markers associated with Wnt inhibitors (2019-09-24),

10. 10341341 - RFID authentication architecture and methods for RFID authentication (2019-07-02),

11. 10277401 - Systems and methods for authenticating and providing anti-counterfeiting features for important documents (2019-04-30),

12. 10166293 - Reduced-viscosity concentrated protein formulations (2019-01-01),

13. 10104542 - Systems and methods for preventing transmitted cryptographic parameters from compromising privacy (2018-10-16),

14. 10034940 - High concentration antibody and protein formulations (2018-07-31),

15. 9843580 - RFID authentication architecture and methods for RFID authentication (2017-12-12),

Title: Innovative Contributions of Jun Liu in Pharmaceutical Formulations

Introduction

Jun Liu is a prominent inventor located in San Diego, California, recognized for his significant contributions in the field of pharmaceutical formulations. With an impressive portfolio of 46 patents, his work has advanced the development of stable and effective therapeutic solutions.

Latest Patents

Among his latest patents, Jun Liu's notable inventions include the development of stable aqueous formulations of aflibercept. This formulation contains a therapeutically effective amount of aflibercept and is characterized by being free of organic co-solvents and buffers. He has also developed stable anti-CD79B immunoconjugate formulations, which consist of pharmaceutical compositions with an anti-CD79b immunoconjugate and surfactants. These formulations are particularly significant for cancer treatment, highlighting his innovative approach to enhancing drug stability and efficacy.

Career Highlights

Jun Liu has had a successful career with key roles in renowned companies such as Neology, Inc. and Genentech, Inc. His work in these organizations has allowed him to focus on developing groundbreaking pharmaceutical products and contributing to the evolution of drug formulation techniques.

Collaborations

Throughout his career, Jun Liu has collaborated with notable colleagues, including Steven J. Shire and Jeffrey Zhu. These partnerships have facilitated a dynamic exchange of ideas and expertise, leading to the successful completion of various projects and patents that have a lasting impact in the pharmaceutical industry.

Conclusion

In conclusion, Jun Liu's pioneering work in pharmaceutical formulations has not only garnered him numerous patents but also established him as a key figure in the field. His commitment to innovation and collaboration continues to drive advancements that promote better health outcomes.